Journal Information
Vol. 45. Issue 4.
Pages 187-195 (April 2009)
Share
Share
Download PDF
More article options
Vol. 45. Issue 4.
Pages 187-195 (April 2009)
Review article
Full text access
Biological Safety in the Storage and Transport of Biological Specimens From Patients With Respiratory Diseases Used in Research Settings
Seguridad biológica en la preservación y el transporte de muestras biológicas obtenidas en el ámbito de las enfermedades respiratorias y destinadas a la investigación
Visits
7567
Núria Somoza, Montserrat Torà
Corresponding author
mtora@imim.es

Corresponding author.
Servicios Científico-Técnicos, IMIM-Hospital del Mar, Universitat Autònoma de Barcelona (UDIMAS-UAB), Barcelona, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Major advances in genomics and proteomics have prompted the creation of biological specimen collections and biobanks for use in biomedical research. These specimen collections and the wealth of data they generate will allow longitudinal studies to be conducted and subproducts such as DNA or RNA to be obtained. They may even be used in future studies.

To ensure specimen integrity, from the outset it is necessary to define procedures for sampling, transport and storage, the subproducts to be obtained, and the end purpose, as well as to address biosafety issues and arrange for suitable equipment monitoring. Strict control of these conditions will confer added value on the specimens, as quality and traceability would be assured.

This article aims to provide a general overview of the recommendations concerning biological safety, transport, and storage of biological specimens for biomedical research into respiratory diseases in accordance with current legislation.

Keywords:
Biological specimen
Biosafety
Storage
Biobank
Respiratory diseases
Resumen

Los grandes avances de la genómica y la proteómica han propiciado la creación de colecciones de muestras biológicas y de biobancos destinados a la investigación biomédica. Estas colecciones, y sus múltiples datos asociados, permitirán realizar estudios longitudinales, obtener subproductos como ADN o ARN e incluso prever estudios futuros.

Para mantener la integridad de las muestras se deberán diseñar desde el principio los procedimientos de obtención, transporte, subproductos que se obtendrán, condiciones de conservación, destino final y bioseguridad, así como disponer de una supervisión adecuada de los equipos. El control de todas estas condiciones proporcionará valor añadido a las muestras, ya que permitirá asegurar su calidad y trazabilidad.

Nos proponemos ofrecer una visión general de las recomendaciones relativas a la seguridad biológica, transporte y conservación de muestras biológicas destinadas a la investigación biomédica en el ámbito de las enfermedades respiratorias, de acuerdo con la legislación vigente.

Palabras clave:
Muestra biológica
Bioseguridad
Conservación
Biobanco
Enfermedades respiratorias
Full text is only aviable in PDF
References
[1.]
A. Cambon-Thomsen, E. Rial-Sebbag, B.M. Knoppers.
Trends in ethical and legal frameworks for the use of human biobanks.
Eur Respir J, 30 (2007), pp. 373-382
[2.]
Ley 14/2007, de 3 de julio, de investigación biomédica Spanish official state gazette [BOE], 159, dated July 4, 2007.
[3.]
Real Decreto 664/1997, de 12 de mayo, sobre la protección de los trabajadores contra los riesgos relacionados con la exposición a agentes biológicos durante el trabajo. Spanish official state gazette [BOE], 124, dated May 24, 1997.
[4.]
Organización Mundial de la Salud. Manual de bioseguridad en el laboratorio. 3rd ed. Geneva, Switzerland: World Health Organization; 2005
[5.]
International Society for Biological and Environmental Repositories (ISBER).
2008 best practices for repositories: collection, storage, retrieval and distribution of biological materials for research.
Cell Preservation Technology, 6 (2008), pp. 3-58
[6.]
OECD Best Practice Guidelines for Biological Resource Centres, 2007. Available from: http://www.wfcc.info/Documents/OECD.pdf
[7.]
IARC (International Agency for Research on Cancer). Working Group Reports. Common minimum technical standards and protocols for biological resource centres dedicated to cancer research. Volume 2, 2007. Available from: http://www.iarc.fr/en/Publications/PDFs-online/IARC-Working-Group-Reports/Common-Minimum-Technical-Standards-and-Protocols-for-Biological-Resource-Centres-dedicated-to-Cancer-Research.
[8.]
J. Sellarés, S. Mas, E. Melo, F. Sánchez, J. Marín, J. Gea, et al.
Oxidative stress time course in the rat diaphragm after freezing-thawing cycles.
Respir Physiol Neurobiol, 155 (2007), pp. 156-166
[9.]
M.M. Morente, R. Mager, S. Alonso, F. Pezzella, A. Spatz, K. Knox, et al.
TuBaFrost 2: standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network.
Eur J Cancer, 42 (2006), pp. 2684-2691
[10.]
A. Almeida, J. Paul Thiery, H. Magdelénat, F. Radvanyi.
Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling.
Anals Biochem, 328 (2004), pp. 101-108
[11.]
A. Spruessel, G. Steimann, M. Jung, S.A. Lee, T. Carr, A.K. Fentz, et al.
Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumour excision.
Biotechniques, 36 (2004), pp. 1030-1037
[12.]
J. Huang, R. Qi, J. Quackenbush, E. Dauway, E. Lazaridis, T. Yeatman.
Effects of ischemia on gene expression.
J Surg Res, 99 (2001), pp. 222-227
[13.]
T.Y. Chu, K.S. Hwang, M.H. Yu, H.S. Lee, H.C. Lai, J.Y. Liu.
A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites.
Int J Gynecol Cancer, 12 (2002), pp. 171-176
[14.]
S.J. Qualman, M. France, W.E. Grizzle, V.A. LiVolsi, C.A. Moskaluk, N.C. Ramírez, et al.
Establishing a tumour bank: banking, informatics and ethics.
Br J Cancer, 90 (2004), pp. 1115-1119
[15.]
N.T. Holland, M.T. Smith, B. Eskenazi, M. Bastaki.
Biological sample collection and processing for molecular epidemiological studies.
Mutat Res, 543 (2003), pp. 217-234
[16.]
R.V. House.
Cytokine measurement techniques for assessing hypersensitivity.
Toxicology, 158 (2001), pp. 51-58
[17.]
K.S. Rønningen, L. Paltiel, H.M. Meltzer, R. Nordhagen, K.K. Lie, R. Hovengen, et al.
The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years.
Eur J Epidemiol, 21 (2006), pp. 619-625
[18.]
V.W. Jaddoe, R. Bakker, C.M. Van Duijn, A.J. Van der Heijden, J. Lindemans, J.P. Mackenbach, et al.
The Generation R Study Biobank: a resource for epidemiological studies in children and their parents.
Eur J Epidemiol, 22 (2007), pp. 917-923
[19.]
P. Elliott, T.C. Peakman, On behalf of UK Biobank.
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.
Int J Epidemiol, 37 (2008), pp. 234-244
[20.]
R.E. Banks.
Preanalytical influences in clinical proteomic studies: raising awareness of fundamental issues in sample banking.
[21.]
J.H. Van Geest-Daalderop, A.B. Mulder, L.J. Boonman-de Winter, M.M. Hoekstra, A.M. Van den Besselaar.
Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.
Clin Chem, 51 (2005), pp. 561-568
[22.]
M. Bull, D. Lee, J. Stucky, Y.L. Chiu, A. Rubin, H. Horton, et al.
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.
J Immunol Methods, 322 (2007), pp. 57-69
[23.]
C.A. Kleeberger, R.H. Lyles, J.B. Margolick, C.R. Rinaldo, J.P. Phair, J.V. Giorgi.
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.
Clin Diagn Lab Immunol, 6 (1999), pp. 14-19
[24.]
S. Tremblay, E.W. Khandjian.
Successful use of long-term frozen lymphocytes for the establishment of lymphoblastoid cell lines.
Clin Biochem, 31 (1998), pp. 555-556
[25.]
J.C. Beck, C.M. Beiswanger, E.M. John, E. Satariano, D. West.
Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies.
Cancer Epidemiol Biomarkers Prev, 10 (2001), pp. 551-554
[26.]
M.T. Landi, N. Caporaso.
Sample collection, processing and storage.
IARC Sci Publ, 142 (1997), pp. 223-236
[27.]
K. Steinberg, J. Beck, D. Nickerson, M. García-Closas, M. Gallagher, M. Caggana, et al.
DNA banking for epidemiologic studies: a review of current practices.
Epidemiology, 13 (2002), pp. 246-254
[28.]
R. Djukanoviç, P.J. Sterk, J.V. Fahy, F.E. Hargreave.
Standardised methodology of sputum induction and processing.
Eur Respir J Suppl, 37 (2002), pp. 1S-2S
[29.]
C. Bergeron, M.K. Tulic, Q. Hamid.
Tools used to measure airway remodelling in research.
Eur Respir J, 29 (2007), pp. 596-604
[30.]
L.I. Sikkeland, J. Kongerud, A.M. Stangeland, T. Haug, N.E. Alexis.
Macrophage enrichment from induced sputum.
Thorax, 62 (2007), pp. 558-559
[31.]
S.A. Kharitonov, P.J. Barnes.
Exhaled markers of pulmonary disease.
Am J Respir Crit Care Med, 163 (2001), pp. 1693-1722
[32.]
American Thoracic Society; European Respiratory Society.
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.
Am J Respir Crit Care Med, 171 (2005), pp. 912-930
[33.]
I. Horváth, J. Hunt, P.J. Barnes, K. Alving, A. Antczak, E. Baraldi, et al.
ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions.
Eur Respir J, 26 (2005), pp. 523-548
[34.]
H. Lehtonen, P. Oksa, L. Lehtimäki, A. Sepponen, R. Nieminen, H. Kankaanranta, et al.
Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
Thorax, 62 (2007), pp. 602-607
[35.]
H.Y. Reynolds.
Use of bronchoalveolar lavage in humans — past necessity and future imperative.
Lung, 178 (2000), pp. 271-293
[36.]
S.L. Cheng, H.C. Wang, C.J. Yu, P.C. Yang.
Increased expression of placenta growth factor in COPD.
Thorax, 63 (2008), pp. 500-506
[37.]
C. Disdier Vicente, F. Rodríguez de Castro.
Punción transbronquial aspirativa.
Arch Bronconeumol, 36 (2000), pp. 580-593
[38.]
G. Fernández-Esparrach, M. Pellisé, M. Solé, J. Belda, O. Sendino, J. Llach, et al.
Valor de la punción aspirativa con aguja fina guiada por ultrasonografía endoscópica en el diagnóstico de las lesiones mediastínicas.
Arch Bronconeumol, 43 (2007), pp. 219-224
[39.]
M. Eikmans, H.J. Baelde, E. De Heer, J.A. Bruijn.
Processing renal biopsies for diagnostic mRNA quantification: improvement of RNA extraction and storage conditions.
J Am Soc Nephrol, 11 (2000), pp. 868-873
[40.]
S.J. Kim, D.J. Dix, K.E. Thompson, R.N. Murrell, J.E. Schmid, J.E. Gallagher, et al.
Effects of storage, RNA extraction, genechip type, and donor sex on gene expression profiling of human whole blood.
Clin Chem, 53 (2007), pp. 1038-1045
[41.]
M.F. Burger, E.Y. Song, J.W. Schumm.
Buccal DNA samples for DNA typing: new collection and processing methods.
Biotechniques, 39 (2005), pp. 257-261
[42.]
A.J. Sigurdson, M. Ha, M. Cosentino, T. Franklin, K.A. Haque, Y. Qi, et al.
Long-term storage and recovery of buccal cell DNA from treated cards.
Cancer Epidemiol Biomarkers Prev, 15 (2006), pp. 385-388
[43.]
D. Rajendram, R. Ayenza, F.M. Holder, B. Moran, T. Long, H.N. Shah.
Long-term storage and safe retrieval of DNA from microorganisms for molecular analysis using FTA matrix cards.
J Microbiol Methods, 67 (2006), pp. 582-592
[44.]
K. Galaal, M. Meirovitz, R. Hussain, L. Allcroft, N. Sullivan, A. Lopes, et al.
The feasibility of storing ovarian tumor cells on databasing paper: establishing a library of ovarian cancer DNA.
Int J Gynecol Cancer, 17 (2007), pp. 94-100
[45.]
D. Woodrum, C. French, L.B. Shamel.
Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions.
Urology, 48 (1996), pp. 33-39
[46.]
D.A. Scaramuzzino, K. Schulte, B.N. Mack, T.F. Soriano, H.A. Fritsche.
Five-year stability study of free and total prostate-specific antigen concentrations in serum specimens collected and stored at −70 degrees C or less.
Int J Biol Markers, 22 (2007), pp. 206-213
[47.]
M. Basit, N. Bakshi, M. Hashem, Z. Allebban, N. Lawson, H.S. Rosman, et al.
The effect of freezing and long-term storage on the stability of cardiac troponin T.
Am J Clin Pathol, 128 (2007), pp. 164-167
[48.]
W.J. Shih, P.S. Bachorik, J.A. Haga, G.L. Myers, E.A. Stein.
Estimating the long-term effects of storage at −70 degrees C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera.
Clin Chem, 46 (2000), pp. 351-364
[49.]
World Health Organization. Guidance on the regulations for the transport of infectious substances 2007-2008. Available from: http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_EPR_2007_2cc.pdf
[50.]
International Air Transport Association. Infectious Substances Shipping Guidelines. Montreal-Geneva: IATA; 2006
[51.]
Real Decreto 65/2006, de 30 de enero, por el que se establecen requisitos para la importación y exportación de muestras biológicas. Spanish official state journal [BOE], 32, dated Feburary 7, 2006.
[52.]
G. Davey Smith, S. Ebrahim, S. Lewis, A.L. Hansell, L.J. Palmer, P.R. Burton.
Genetic epidemiology and public health: hope, hype, and future prospects.
Lancet, 366 (2005), pp. 1484-1498
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?